Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03548558 · ClinicalTrials.gov registry record · NA
Testing Means to Scale Early Childhood Development Interventions in Rural Kenya
A NA study of Early Child Development, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 1,152
- Enrollment target
- 1
- Study location
NCT03548558: Completed NA study of Early Child Development, sponsored by University of Southern California.
NCT03548558 is a NA study of Early Child Development that has completed, run by University of Southern California. The registered enrollment target is 1,152 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (18% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03548558, a NA study of Early Child Development, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,152 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to experimentally test the effectiveness and cost-effectiveness of competing models of delivery of an Early Childhood Development (ECD) intervention in rural Kenya to determine how to maximize their reach to improve child cognitive, language and relevant psychosocial outcomes. The study will also include a longer-term evaluation of sustained impacts; an examination of the pathways of change leading to intervention impacts to inform policy; and examination of the role of paternal involvement on child development. Findings will provide policy makers with rigorous evidence of how best to expand ECD interventions in low-resource rural settings to improve child developmental outcomes for both the short-and longer-term.
Primary Outcome
The Bayley Scales of Infant Development 3rd edition (Bayley's III), is validated in African settings and provides measures for all dimensions of child development up to 42 months of age. The official age-standardized cognitive, receptive language, and expressive language scales have 0-19 ranges with higher values denoting better scores. At month 11/endline survey, cognitive, receptive language, and expressive language scales were collected. At baseline, cognitive and receptive language were coll
Conditions Studied
Interventions
- BEHAVIORAL Group sessions
- BEHAVIORAL Group+Home sessions
- BEHAVIORAL Booster sessions
- BEHAVIORAL Fathers invited
Study Locations (1)
California
- USC - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,152 participants |
| Start Date | 2018-10-01 |
| Est. Completion | 2021-10-15 |
| Phase | NA |
What the finished NCT03548558 record still lists
NCT03548558 is an interventional study that assigns participants to a tested intervention. Its 1,152 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (18% lower).
The record links to 1 condition, with Early Child Development appearing as the primary indexed condition, and to 4 interventions - of which Group sessions is the first listed.
NCT03548558 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03548558 about?
NCT03548558 is a clinical study titled "Testing Means to Scale Early Childhood Development Interventions in Rural Kenya". This study aims to experimentally test the effectiveness and cost-effectiveness of competing models of delivery of an Early Childhood Development (ECD) intervention in rural Kenya to determine how to maximize their reach to improve child cognitive, language and relevant psychosocial outcomes. The st...
What is the current status of trial NCT03548558?
This trial is currently completed. It is a NA study. The enrollment target is 1,152 participants. The study started on 2018-10-01. Estimated completion is 2021-10-15.
What conditions does trial NCT03548558 study?
This clinical trial studies the following conditions: Early Child Development.
What interventions are being tested in trial NCT03548558?
The interventions under investigation include: Group sessions (BEHAVIORAL), Group+Home sessions (BEHAVIORAL), Booster sessions (BEHAVIORAL), Fathers invited (BEHAVIORAL).
Who is sponsoring clinical trial NCT03548558?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03548558 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03548558's enrollment target sits among peer trials
1,152 92nd of 2000 higher than 1,909 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04474301 · 1,152 participants
Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic
- NCT05564026 · 1,151 participants
Molecular Epidemiology of Pediatric Germ Cell Tumors
- NCT06408181 · 1,150 participants · Phase 3
APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia
- NCT06528314 · 1,150 participants · Phase 3
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI